In the 1980s, Breakthrough T1D-funded researcher Pauline Kay Lund, Ph.D., was the first to clone the hormone glucagon and discover two new hormones, one of which was GLP-1
Decongestants can raise blood pressure, which compounds any existing hypertension managed by your medical provider
Knowing these differences helps you make an informed decision about which medication aligns with your health goals and tolerance level
Obesity, commonly present in individuals with type 2 diabetes, independently increases venous thromboembolism risk through mechanical factors, chronic inflammation, and altered coagulation profiles
Beyond insulation, the body's total energy expenditure typically declines with weight loss, which includes a reduction in heat production as a metabolic byproduct
Significant weight loss achieved with semaglutide may necessitate levothyroxine dose adjustment